Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Aug;29(2):369–375. doi: 10.1128/iai.29.2.369-375.1980

Cell-Mediated and Humoral Immunity to Herpesviruses During and After Herpes Zoster Infections

Ole S Sørensen 1, Sven Haahr 1, Anné Møller-Larsen 1, Kaj Wildenhoff 2
PMCID: PMC551127  PMID: 6163709

Abstract

The influence of herpes zoster virus infection on cell-mediated and humoral immunity to varicella-zoster virus (VZV), cytomegalovirus, and herpes simplex virus (HSV) was followed in 17 zoster patients from the first week to 6 months after start of eruptions. The clinical responses were registered and correlated to the immune responses. A significant depression in blast transformation on stimulation of lymphocytes with all three antigens was found on days 1 to 5 compared with transformations later after zoster eruptions and compared with controls. Phytohemagglutinin exhibited the same stimulation in the different groups and controls. No significant differences in interferon production in the various groups and controls were found on stimulation with the VZV and HSV antigens. All zoster patients became seropositive by complement fixation to VZV a few days after start of the zoster eruption. Two zoster patients showed a fourfold rise in complement fixation antibodies to HSV. Three patients had changes in complement fixation titers to cytomegalovirus, which could indicate new infection or reactivation of infection with this virus. A significant lower transformation index to VZV was found during the first 9 days in zoster patients with fever compared with patients without fever. The relevance of this observation is discussed in relation to a previous similar observation from our group.

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen H. K., Godtfredsen A., Spencer E. S. Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens. Scand J Infect Dis. 1971;3(3):183–187. doi: 10.3109/inf.1971.3.issue-3.01. [DOI] [PubMed] [Google Scholar]
  2. Arvin A. M., Pollard R. B., Rasmussen L. E., Merigan T. C. Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. J Infect Dis. 1978 May;137(5):531–540. doi: 10.1093/infdis/137.5.531. [DOI] [PubMed] [Google Scholar]
  3. BENTZON J. W. The effect of certain infectious diseases on tuberculin allergy. Tubercle. 1953 Feb;34(2):34–41. doi: 10.1016/s0041-3879(53)80013-9. [DOI] [PubMed] [Google Scholar]
  4. Berkovich S., Starr S. Effects of live type 1 poliovirus vaccine and other viruses on the tuberculin test. N Engl J Med. 1966 Jan 13;274(2):67–72. doi: 10.1056/NEJM196601132740203. [DOI] [PubMed] [Google Scholar]
  5. Haahr S., Rasmussen L., Merigan T. C. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect Immun. 1976 Jul;14(1):47–54. doi: 10.1128/iai.14.1.47-54.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mackowiak P. A. Microbial synergism in human infections (second of two parts). N Engl J Med. 1978 Jan 12;298(2):83–87. doi: 10.1056/NEJM197801122980206. [DOI] [PubMed] [Google Scholar]
  7. Møller-Larsen A., Haahr S., Black F. T. Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis. Infect Immun. 1978 Nov;22(2):445–451. doi: 10.1128/iai.22.2.445-451.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Notkins A. L., Mergenhagen S. E., Howard R. J. Effect of virus infections on the function of the immune system. Annu Rev Microbiol. 1970;24:525–538. doi: 10.1146/annurev.mi.24.100170.002521. [DOI] [PubMed] [Google Scholar]
  9. Pollard R. B., Rand K. H., Arvin A. M., Merigan T. C. Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis. 1978 May;137(5):541–549. doi: 10.1093/infdis/137.5.541. [DOI] [PubMed] [Google Scholar]
  10. Rand K. H., Rasmussen L. E., Pollard R. B., Arvin A., Merigan T. C. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977 Jun 16;296(24):1372–1377. doi: 10.1056/NEJM197706162962402. [DOI] [PubMed] [Google Scholar]
  11. Roberts N. J., Jr, Steigbigel R. T. Hyperthermia and human leukocyte functions: effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils. Infect Immun. 1977 Dec;18(3):673–679. doi: 10.1128/iai.18.3.673-679.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Russell A. S., Maini R. A., Bailey M., Dumonde D. C. Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol. 1973 Jun;14(2):181–185. [PMC free article] [PubMed] [Google Scholar]
  13. STARR S., BERKOVICH S. THE DEPRESSION OF TUBERCULIN REACTIVITY DURING CHICKENPOX. Pediatrics. 1964 May;33:769–772. [PubMed] [Google Scholar]
  14. Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Valle M. J., Jordan G. W., Haahr S., Merigan T. C. Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol. 1975 Jul;115(1):230–233. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES